Millennium Management’s iTeos Therapeutics ITOS Stock Holding History

Millennium Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-342,500	Closed	-$3.41M	–	6243
2025 Q2	$3.41M	Buy	+342,500	New	+$2.76M	﹤0.01%	3371
2023 Q1	–	Sell	-50,000	Closed	-$977K	–	6597
2022 Q4	$977K	Buy	+50,000	New	+$977K	﹤0.01%	4192

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Millennium Management's ITOS Position: Q3 2025 in Review

Millennium Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 477,189 shares — an estimated $4.76M sold.

Millennium Management first reported a position in ITOS in Q4 2020 and held it in 18 quarters. The position peaked at $17.1M in Q4 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Millennium Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Millennium Management sold 477,189 iTeos Therapeutics shares in Q3 2025, an estimated $4.76M.
Millennium Management first reported a position in iTeos Therapeutics in Q4 2020 and held it in 18 quarters.
Millennium Management's iTeos Therapeutics position peaked at $17.1M in Q4 2022.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.